Returpen.dk post-consumer injection pens - The R.U.M.- Pharma Blue - is made of this

Wehlers.com drives a business model that ensures the take back of chairs no longer in use. FULL circular economy.

After use the chair will be recycled to prevent waste. Simply because if this was not the case it makes no difference to make the R.U.M.- Chair of waste and then be linear in its business model – Then the waste will become waste again. Not good for the World, the future of resources & challenges with greenhouse gases.

Post Consumer waste from Returpen.dk are used for the manufacturing of the R.U.M.- Chair and collected back after use. The Pharma Companies involved in this are. Compliments to the Partners for taking circular action - Together:

Novo Nordisk, (novonordisk.dk) - Lilly, (lilly.com) - Sanofi, (sanofi.com) - Merck, (merckgroup.com)- Apotek, (apotek.dk) - Diabetesforeningen, (diabetes.dk) - Lægemiddelindustrien, (lif.dk) - Steno Diabetescenter, (stenoaarhus.dk) - Regoinmidtjylland, (rm.dk) - Steno Diabetescenter Copenhagen, (sdcc.dk)

Type1, (videncenterfordiabetes.dk) - Nomeco, (nomeco.dk) - Zirq Solutions, (zirqsulutions.com) - Tjellesen Max Jenne, (tmj.dk)

Novo Nordisk has shown a commitment to sustainability and social responsibility, which aligns with the principles of B Corporations (B Corps) and circular businesses. B Corps are certified companies that meet high standards of social and environmental performance, accountability, and transparency.

Novo Nordisk's initiatives could include promoting sustainable practices in its supply chain, reducing environmental impact through circular economy principles (like reusing materials and reducing waste), and supporting community health initiatives. By favoring circular businesses, Novo Nordisk may enhance its sustainability goals while also fostering innovation and collaboration within the industry.

Change the furniture industry – For Good